RT @cancer_K2A: 4/10 There are a growing number of studies that've demonstrated the #costeffectiveness of #cancer #fearofrecurrence interve…
RT @cancer_K2A: 4/10 There are a growing number of studies that've demonstrated the #costeffectiveness of #cancer #fearofrecurrence interve…
4/10 There are a growing number of studies that've demonstrated the #costeffectiveness of #cancer #fearofrecurrence interventions including great work by @NKasparian https://t.co/Blw2NwYOmx @Mariekevdwal https://t.co/SlHeBW2u4q & the #ConquerFear tea
RT @AACBT_org_au: Blended #CognitiveBehaviourTherapy for cancer survivors with fear of recurrence is clinically and statistically more effe…
Blended #CognitiveBehaviourTherapy for cancer survivors with fear of recurrence is clinically and statistically more effective than care as usual in the long-term. https://t.co/gA0pG07Y5Z https://t.co/w8HPVNgMNq
RT @cancer_K2A: New report shows blended #CBT for #cancer #fearofrecurrence (#SWORD) is statistically & clinically more effective than CAU…
So important to see economic valuations of interventions. The SWORD study is an effective blended treatment for #FCR. Part online and part face to face. This study shows acceptable cost effectiveness.
RT @cancer_K2A: New report shows blended #CBT for #cancer #fearofrecurrence (#SWORD) is statistically & clinically more effective than CAU…
RT @cancer_K2A: New report shows blended #CBT for #cancer #fearofrecurrence (#SWORD) is statistically & clinically more effective than CAU…
RT @cancer_K2A: New report shows blended #CBT for #cancer #fearofrecurrence (#SWORD) is statistically & clinically more effective than CAU…
RT @cancer_K2A: New report shows blended #CBT for #cancer #fearofrecurrence (#SWORD) is statistically & clinically more effective than CAU…
RT @cancer_K2A: New report shows blended #CBT for #cancer #fearofrecurrence (#SWORD) is statistically & clinically more effective than CAU…
New report shows blended #CBT for #cancer #fearofrecurrence (#SWORD) is statistically & clinically more effective than CAU at 15 months post-treatment & a relatively inexpensive intervention w/ similar costs & QALYs as CAU https://t.co/U5IhX1AH